Challenges and opportunities for discovery of disease biomarkers using urine proteomics

Pediatrics International

Volumn 53, Issue 1, 2011, Pages 1-6

  Kentsis, Alex ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

biological marker; individualized medicine; mass spectrometry; proteomics; urine

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; ARTIFACT; DISEASE MARKER; FRACTIONATION; HUMAN; MASS SPECTROMETRY; METHODOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; URINALYSIS;

BIOLOGICAL MARKERS; HUMANS; MASS SPECTROMETRY; PROTEINURIA; PROTEOMICS; URINALYSIS; URINE;

EID: 79951999068     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03253.x     Document Type: Article

References (54)

1. Kharbanda AB, Taylor GA, Fishman SJ, Bachur RG,. A clinical decision rule to identify children at low risk for appendicitis. Pediatrics 2005; 116: 709-16. (Pubitemid 44336689)
2. Gedalia A,. Kawasaki disease: 40 years after the original report. Curr. Rheumatol. Rep. 2007; 9: 336-41. (Pubitemid 47262615)
3. Anderson NL, Anderson NG,. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics. 2002; 1: 845-67.
4. Thongboonkerd V,. Practical points in urinary proteomics. J. Proteome. Res. 2007; 6: 3881-90. (Pubitemid 350032551)
5. Yamamoto T, Langham RG, Ronco P, Knepper MA, Thongboonkerd V,. Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA. Proteomics 2008; 8: 2156-9. (Pubitemid 351898019)
6. Mallick P, Kuster B,. Proteomics: a pragmatic perspective. Nat. Biotechnol. 2010; 28: 695-709.
7. Pisitkun T, Shen RF, Knepper MA,. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 13368-73. (Pubitemid 39209672)
8. Gonzales PA, Pisitkun T, Hoffert JD, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 2009; 20: 363-379.
9. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M,. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome. Biol. 2006; 7: R80.
10. Li QR, Fan KX, Li RX, et al. A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine. Rapid. Commun. Mass. Spectrom. 2010; 24: 823-32.
11. Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur RG, Steen H,. Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics. Clin. Appl. 2009; 3: 1052-61.
12. Sharma K, Lee S, Han S, et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005; 5: 2648-55. (Pubitemid 40966492)
13. Pieper R, Gatlin CL, McGrath AM, et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004; 4: 1159-74. (Pubitemid 38445973)
14. Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF,. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass. Spectrom. Rev. 2009; 28: 703-724.
15. Jurgens M, Appel A, Heine G, et al. Towards characterization of the human urinary peptidome. Comb. Chem. High. Throughput. Screen 2005; 8: 757-65. (Pubitemid 41771576)
16. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004; 15: 219-27. (Pubitemid 38020714)
17. Zhou H, Pisitkun T, Aponte A, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006; 70: 1847-57. (Pubitemid 44684818)
18. Zhang X, Jin M, Wu H, et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 2008; 74: 799-807.
19. Khurana M, Traum AZ, Aivado M, et al. Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr. Nephrol. 2006; 21: 1257-65. (Pubitemid 44203451)
20. Dihazi H, Muller GA, Lindner S, et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin. Chem. 2007; 53: 1636-45. (Pubitemid 47340060)
21. Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 2006; 12: 398-400.
22. Gaston KE, Grossman HB,. Proteomic assays for the detection of urothelial cancer. Methods Mol. Biol. 2010; 641: 303-23.
23. Canter MP, Graham CA, Heit MH, et al. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects. Am. J. Obstet. Gynecol. 2008; 198: 553.e1-6.
24. Theodorescu D, Wittke S, Ross MM, et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006; 7: 230-40. (Pubitemid 43286453)
25. Zimmerli LU, Schiffer E, Zurbig P, et al. Urinary proteomic biomarkers in coronary artery disease. Mol. Cell Proteomics. 2008; 7: 290-8. (Pubitemid 351298443)
26. Petri AL, Simonsen AH, Yip TT, et al. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Acta Obstet. Gynecol. Scand. 2009; 88: 18-26.
27. Buhimschi IA, Zhao G, Funai EF, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am. J. Obstet. Gynecol. 2008; 199: 551.e1-16.
28. Flint RS, Phillips AR, Farrant GJ, et al. Probing the urinary proteome of severe acute pancreatitis. HPB 2007; 9: 447-55. (Pubitemid 350215041)
29. Kentsis A, Lin YY, Kurek K, et al. Discovery and validation of urine markers of acute pediatric appendicitis using high accuracy mass spectrometry. Ann. Emerg. Med. 2010; 55: 62-70.
30. Chen HS, Rejtar T, Andreev V, Moskovets E, Karger BL,. Enhanced characterization of complex proteomic samples using LC-MALDI MS/MS: exclusion of redundant peptides from MS/MS analysis in replicate runs. Anal. Chem. 2005; 77: 7816-25. (Pubitemid 41746251)
31. Wang N, Li L,. Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis. Anal. Chem. 2008; 80: 4696-710. (Pubitemid 351842350)
32. Qian WJ, Jacobs JM, Liu T, Camp DG 2nd, Smith RD,. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell Proteomics. 2006; 5: 1727-44. (Pubitemid 44696109)
33. Righetti PG, Boschetti E, Lomas L, Citterio A,. Protein equalizer technology: the quest for a "democratic proteome". Proteomics 2006; 6: 3980-92.
34. Bellei E, Bergamini S, Monari E, et al. High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino. Acids 2010; in press.
35. Yates JR, Ruse CI, Nakorchevsky A,. Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 2009; 11: 49-79.
36. Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR,. Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann. Intern. Med. 1982; 97: 516-19. (Pubitemid 12000694)
37. Mazzoni MB, Kottanatu L, Simonetti GD, et al. Renal vein obstruction and orthostatic proteinuria: a review. Nephrol. Dial. Transplant. 2010; in press.
38. Brandt JR, Jacobs A, Raissy HH, et al. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children. Pediatr. Nephrol. 2010; 25: 1131-7.
39. Okon EB, Hranislavljevic J, Marjanovic V, et al. [Diurnal fluctuations of protein contents and the pH dependence of beta2-microglobulin stability in urine]. Izv. Akad. Nauk. Ser. Biol. 2008; 1: 46-52.
40. Ginsberg JM, Chang BS, Matarese RA, Garella S,. Use of single voided urine samples to estimate quantitative proteinuria. N. Engl. J. Med. 1983; 309: 1543-6. (Pubitemid 14212836)
41. Domon B, Aebersold R,. Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 2010; 28: 710-21.
42. Lundgren DH, Hwang SI, Wu L, Han DK,. Role of spectral counting in quantitative proteomics. Expert. Rev. Proteomics. 2010; 7: 39-53.
43. Ambroise C, McLachlan GJ,. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 6562-6. (Pubitemid 34526172)
44. Sadygov RG, Liu H, Yates JR,. Statistical models for protein validation using tandem mass spectral data and protein amino acid sequence databases. Anal. Chem. 2004; 76: 1664-71. (Pubitemid 38338411)
45. Elias JE, Gygi SP,. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007; 4: 207-14. (Pubitemid 46358868)
46. Gupta N, Pevzner PA,. False discovery rates of protein identifications: a strike against the two-peptide rule. J. Proteome. Res. 2009; 8: 4173-81.
47. Choi H, Fermin D, Nesvizhskii AI,. Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell Proteomics. 2008; 7: 2373-85.
48. Hilario M, Kalousis A,. Approaches to dimensionality reduction in proteomic biomarker studies. Brief. Bioinform. 2008; 9: 102-18. (Pubitemid 351516997)
49. Knepper MA,. Common sense approaches to urinary biomarker study design. J. Am. Soc. Nephrol. 2009; 20: 1175-8.
50. Radivojac P, Peng K, Clark WT, et al. An integrated approach to inferring gene-disease associations in humans. Proteins 2008; 72: 1030-7. (Pubitemid 352000879)
51. Hodges PE, Carrico PM, Hogan JD, et al. Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 2002; 30: 137-41. (Pubitemid 34679524)
52. The Universal Protein Resource (UniProt). Nucleic Acids Res. 2010; 38 (Database issue): D142-8.
53. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 2008; 358: 28-35.
54. Schuchman EH,. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J. Inherit. Metab. Dis. 2007; 30: 654-63. (Pubitemid 47559876)